These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14666671)

  • 1. Constitutive expression of Rb associated protein 46 (RbAp46) reverts transformed phenotypes of breast cancer cells.
    Zhang TF; Yu SQ; Deuel TF; Wang ZY
    Anticancer Res; 2003; 23(5A):3735-40. PubMed ID: 14666671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RbAp46 inhibits estrogen-stimulated progression of neoplastigenic breast epithelial cells.
    Zhang TF; Yu SQ; Wang ZY
    Anticancer Res; 2007; 27(5A):3205-9. PubMed ID: 17970062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible expression of RbAp46 activates c-Jun NH2-terminal kinase-dependent apoptosis and suppresses progressive growth of tumor xenografts in nude mice.
    Zhang TF; Yu SQ; Loggie BW; Wang ZY
    Anticancer Res; 2003; 23(6C):4621-7. PubMed ID: 14981905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive expression of RbAp46 induces epithelial-mesenchymal transition in mammary epithelial cells.
    Li GC; Wang ZY
    Anticancer Res; 2006; 26(5A):3555-60. PubMed ID: 17094482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of RbAp46 facilitates stress-induced apoptosis and suppresses tumorigenicity of neoplastigenic breast epithelial cells.
    Li GC; Guan LS; Wang ZY
    Int J Cancer; 2003 Jul; 105(6):762-8. PubMed ID: 12767060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rb-associated protein 46 (RbAp46) inhibits transcriptional transactivation mediated by BRCA1.
    Chen GC; Guan LS; Yu JH; Li GC; Choi Kim HR; Wang ZY
    Biochem Biophys Res Commun; 2001 Jun; 284(2):507-14. PubMed ID: 11394910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant expression of X-linked genes RbAp46, Rsk4, and Cldn2 in breast cancer.
    Thakur A; Rahman KW; Wu J; Bollig A; Biliran H; Lin X; Nassar H; Grignon DJ; Sarkar FH; Liao JD
    Mol Cancer Res; 2007 Feb; 5(2):171-81. PubMed ID: 17314274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15-hydroxyprostaglandin dehydrogenase is a tumor suppressor of human breast cancer.
    Wolf I; O'Kelly J; Rubinek T; Tong M; Nguyen A; Lin BT; Tai HH; Karlan BY; Koeffler HP
    Cancer Res; 2006 Aug; 66(15):7818-23. PubMed ID: 16885386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO-1 overexpression increases RbAp46 protein stability and suppresses cell growth.
    Giri R; Yeh HH; Wu CH; Liu HS
    Anticancer Res; 2008; 28(6A):3749-56. PubMed ID: 19189660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer.
    Lo TL; Yusoff P; Fong CW; Guo K; McCaw BJ; Phillips WA; Yang H; Wong ES; Leong HF; Zeng Q; Putti TC; Guy GR
    Cancer Res; 2004 Sep; 64(17):6127-36. PubMed ID: 15342396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer.
    Palmieri D; Halverson DO; Ouatas T; Horak CE; Salerno M; Johnson J; Figg WD; Hollingshead M; Hursting S; Berrigan D; Steinberg SM; Merino MJ; Steeg PS
    J Natl Cancer Inst; 2005 May; 97(9):632-42. PubMed ID: 15870434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin.
    Zhang TF; Yu SQ; Guan LS; Wang ZY
    Anticancer Res; 2003; 23(5A):3575-84. PubMed ID: 14666652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
    Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
    Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer.
    Townson SM; Sullivan T; Zhang Q; Clark GM; Osborne CK; Lee AV; Oesterreich S
    Clin Cancer Res; 2000 Sep; 6(9):3788-96. PubMed ID: 10999774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 down-regulation activates estrogen receptor alpha expression and leads to 17beta-estradiol-stimulated mammary tumorigenesis.
    Zhang X; Shen P; Coleman M; Zou W; Loggie BW; Smith LM; Wang Z
    Anticancer Res; 2005; 25(1A):369-75. PubMed ID: 15816560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.